We apologize for Proteopedia being slow to respond. For the past two years, a new implementation of Proteopedia has been being built. Soon, it will replace this 18-year old system. All existing content will be moved to the new system at a date that will be announced here.

2nmy

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2nmy.jpg|left|200px]]
+
{{Seed}}
 +
[[Image:2nmy.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2nmy| PDB=2nmy | SCENE= }}
{{STRUCTURE_2nmy| PDB=2nmy | SCENE= }}
-
'''Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir'''
+
===Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir===
-
==Overview==
+
<!--
-
Saquinavir (SQV), the first antiviral HIV-1 protease (PR) inhibitor approved for AIDS therapy, has been studied in complexes with PR and the variants PR(I) (84V) and PR(V) (82A) containing the single mutations I84V and V82A that provide resistance to all the clinical inhibitors. Atomic resolution crystal structures (0.97-1.25 A) of the SQV complexes were analyzed in comparison to the protease complexes with darunavir, a new drug that targets resistant HIV, in order to understand the molecular basis of drug resistance. PR(I) (84V) and PR(V) (82A) complexes were obtained in both the space groups P2(1)2(1)2 and P2(1)2(1)2(1), which provided experimental limits for the conformational flexibility. The SQV interactions with PR were very similar in the mutant complexes, consistent with the similar inhibition constants. The mutation from bigger to smaller amino acids allows more space to accommodate the large group at P1' of SQV, unlike the reduced interactions observed in darunavir complexes. The residues 79-82 have adjusted to accommodate the large hydrophobic groups of SQV, suggesting that these residues are intrinsically flexible and their conformation depends more on the nature of the inhibitor than on the mutations in this region. This analysis will assist with development of more effective antiviral inhibitors.
+
The line below this paragraph, {{ABSTRACT_PUBMED_17243183}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 17243183 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_17243183}}
==About this Structure==
==About this Structure==
Line 37: Line 41:
[[Category: Saquinavir]]
[[Category: Saquinavir]]
[[Category: V82a]]
[[Category: V82a]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 09:38:59 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 07:10:08 2008''

Revision as of 04:10, 28 July 2008

Image:2nmy.png

Template:STRUCTURE 2nmy

Crystal structure analysis of HIV-1 protease mutant V82A with a inhibitor saquinavir

Template:ABSTRACT PUBMED 17243183

About this Structure

2NMY is a Single protein structure of sequence from Human immunodeficiency virus 1. Full crystallographic information is available from OCA.

Reference

Atomic resolution crystal structures of HIV-1 protease and mutants V82A and I84V with saquinavir., Tie Y, Kovalevsky AY, Boross P, Wang YF, Ghosh AK, Tozser J, Harrison RW, Weber IT, Proteins. 2007 Apr 1;67(1):232-42. PMID:17243183

Page seeded by OCA on Mon Jul 28 07:10:08 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2nmy"
Personal tools